Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Pear Therapeutics, Inc. - Class A Common Stock (NQ: PEAR ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Apr 18, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Pear Therapeutics, Inc. - Class A Common Stock < Previous 1 2 3 4 5 6 7 Next > Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday's Mid-Day Session September 06, 2022 Gainers HyreCar Inc. (NASDAQ: HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist... Via Benzinga South Carolina Department of Corrections and Pear Therapeutics Team up to Support Inmates in Recovery from Substance Use Disorders September 01, 2022 From Pear Therapeutics, Inc. Via Business Wire Where Pear Therapeutics Stands With Analysts August 12, 2022 Pear Therapeutics (NASDAQ:PEAR) has observed the following analyst ratings within the last quarter: Via Benzinga Why PolyPid Dipped Over 73%; Here Are 60 Biggest Movers From Friday September 06, 2022 Gainers Venus Concept Inc. (NASDAQ: VERO) jumped 54.9% to settle at $0.5419 on Friday. The company, last month, posted downbeat quarterly results. Via Benzinga Pear Therapeutics to Participate in Citi’s 17th Annual BioPharma Conference August 31, 2022 From Pear Therapeutics, Inc. Via Business Wire Earnings Scheduled For August 11, 2022 August 11, 2022 Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million. Via Benzinga Where Pear Therapeutics Stands With Analysts July 26, 2022 Within the last quarter, Pear Therapeutics (NASDAQ:PEAR) has observed the following analyst ratings: Via Benzinga Where Pear Therapeutics Stands With Analysts June 24, 2022 Within the last quarter, Pear Therapeutics (NASDAQ:PEAR) has observed the following analyst ratings: Via Benzinga Why Baudax Bio Is Trading Lower By 34%; Here Are 26 Stocks Moving Premarket August 30, 2022 Gainers Mobile Global Esports Inc. (NASDAQ: MGAM) shares rose 28.1% to $3.33 in pre-market trading after gaining over 5% on Monday. The company recently reported an exclusive compression technology... Via Benzinga Why Everbridge Jumped Over 17%; Here Are 90 Biggest Movers From Friday August 29, 2022 Gainers Micro Focus International plc (NYSE: MFGP) shares surged 92% to close at $6.01 on Friday after the company reached an agreement with OpenText to be acquired for $6 billion. Via Benzinga Upstart Digital Health Company, DarioHealth, Announces Significant Contract with National Health Plan Provider, Giving Millions Access to Mental Health Resources August 24, 2022 DarioHealth Corp. (NASDAQ: DRIO) recently announced Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session August 22, 2022 Gainers ABVC BioPharma (NASDAQ:ABVC) shares increased by 12.8% to $0.97 during Monday's after-market session. The company's market cap stands at $31.6 million. Via Benzinga Pear Therapeutics Reports Second Quarter 2022 Results August 11, 2022 From Pear Therapeutics, Inc. Via Business Wire Pear Therapeutics Announces Publication of New Analysis of Real-World Data Showing Reduction in Insomnia Severity, Healthcare Resource Utilization and Associated Costs in Adults Using Somryst® August 10, 2022 From Pear Therapeutics, Inc. Via Business Wire Why Embark Technology Jumped Around 85%; Here Are 108 Biggest Movers From Friday August 15, 2022 Gainers Embark Technology, Inc. (NASDAQ: EMBK) jumped 84.8% to close at $1.07 on Friday after the company reported better-than-expected Q2 EPS results. Via Benzinga Why Twin Vee Powercats Is Trading Higher By Around 90%, Here Are 84 Stocks Moving In Friday's Mid-Day Session August 12, 2022 Gainers Twin Vee Powercats Co. (NASDAQ: VEEE) shares jumped 90% to $7.60 after the company said Q2 sales results were up year over year. Via Benzinga Pear Therapeutics and SelectHealth Announce Coverage to Provide Access to FDA-Authorized Prescription Digital Therapeutic for the Treatment of Opioid Use Disorder August 08, 2022 From Pear Therapeutics, Inc. Via Business Wire Pear Therapeutics and Cove Behavioral Health to Provide Patients Access to Prescription Digital Therapeutic for the Treatment of Opioid Use Disorder August 03, 2022 From Pear Therapeutics, Inc. Via Business Wire Pear Therapeutics to be Added to Russell US Index Series August 02, 2022 From Pear Therapeutics, Inc. Via Business Wire Pear Therapeutics to Issue Second Quarter 2022 Financial Results on Thursday, August 11, 2022 July 28, 2022 From Pear Therapeutics, Inc. Via Business Wire Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate July 26, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Stocks That Hit 52-Week Lows On Friday July 15, 2022 On Friday, 137 stocks made new 52-week lows. Via Benzinga Pear Therapeutics Earnings Perspective: Return On Capital Employed June 21, 2022 According to data from Benzinga Pro, during Q1, Pear Therapeutics's (NASDAQ:PEAR) reported sales totaled $2.75 million. Despite a 62.5% increase in earnings, the company posted a loss of $23.86... Via Benzinga Pear Therapeutics to Participate in the Cowen 7th Annual FutureHealth Conference June 16, 2022 From Pear Therapeutics, Inc. Via Business Wire Pear Therapeutics Announces Three New Board Members June 15, 2022 From Pear Therapeutics, Inc. Via Business Wire 12 Health Care Stocks Moving In Tuesday's Pre-Market Session June 14, 2022 Via Benzinga Pear Therapeutics Announces New 12-Month Analysis Showing Reduction in Healthcare Resource Utilization and Associated Costs in Patients Treated with reSET-O® June 14, 2022 From Pear Therapeutics, Inc. Via Business Wire 93 Biggest Movers From Yesterday June 14, 2022 Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares surged 126% to close at $14.96 on Monday after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in... Via Benzinga 70 Stocks Moving In Monday's Mid-Day Session June 13, 2022 Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares jumped 110% to $13.93 after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in relapsed pediatric... Via Benzinga 91 Biggest Movers From Friday June 13, 2022 Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto. Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.